Published in Comp Med on August 01, 2012
Grape seed powder improves renal failure of chronic kidney disease patients. EXCLI J (2016) 0.76
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
The acute phase response. Immunol Today (1994) 7.53
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr (2005) 6.05
Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev (2010) 4.02
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr (2005) 3.45
Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci (1999) 2.45
Phospholipase A2 biochemistry. Cardiovasc Drugs Ther (2008) 1.93
C-reactive protein: a valuable marker of sepsis. Intensive Care Med (2002) 1.82
Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res (2005) 1.40
Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets (2009) 1.28
Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim Biophys Acta (2000) 1.28
Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest (1995) 1.22
Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta (2007) 1.15
Polyphenols and inflammation: basic interactions. Curr Opin Clin Nutr Metab Care (2007) 1.15
Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun (2001) 1.14
Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta (2010) 1.07
Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol (1999) 1.07
Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat (2005) 1.06
Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta (2005) 1.05
Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest (2001) 1.02
The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res (2010) 1.01
Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunol Lett (1991) 1.01
Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol (1983) 1.00
Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation. Biochim Biophys Acta (2003) 1.00
Purification and characterization of phospholipase A2 released from rat platelets. J Biochem (1987) 0.98
Secretory phospholipase A2 enzymes in atherogenesis. Curr Opin Lipidol (2005) 0.98
Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur J Biochem (1992) 0.97
Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock (2008) 0.92
Dietary supplementation of grape skin extract improves glycemia and inflammation in diet-induced obese mice fed a Western high fat diet. J Agric Food Chem (2011) 0.92
A continuous fluorescence assay for the determination of calcium-dependent secretory phospholipase A2 activity in serum. Clin Chim Acta (2007) 0.90
Route and type of nutrition and surgical stress influence secretory phospholipase A2 secretion of the murine small intestine. JPEN J Parenter Enteral Nutr (2011) 0.89
Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation (1993) 0.88
Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans. J Nutr (2002) 0.87
A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury. Shock (2010) 0.87
Effects of grape pomace antioxidant extract on oxidative stress and inflammation in diet induced obese mice. J Agric Food Chem (2010) 0.86
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor. Biochem Biophys Res Commun (2009) 0.85
Preferential distribution of group-II-like phospholipase A2 in mononuclear phagocytic cells in rat spleen and liver. Eur J Biochem (1991) 0.84
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. Adv Exp Med Biol (1990) 0.84
Selective enhancement of LPS-induced serum TNF-alpha production by carrageenan pretreatment in mice. Gen Pharmacol (1998) 0.82
Sera of patients suffering from inflammatory diseases contain group IIA but not group V phospholipase A(2). Biochim Biophys Acta (2000) 0.80
A comparative analysis of acute-phase proteins as inflammatory biomarkers in preclinical toxicology studies: implications for preclinical to clinical translation. Toxicol Pathol (2009) 0.80
Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1. Chem Biol Interact (2003) 0.79
The effect of phospholipids and fatty acids on tight-junction permeability and bacterial translocation. Pediatr Surg Int (2001) 0.79
LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives. Mediators Inflamm (1993) 0.78
Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia. J Immunother (1991) (1992) 0.78
Distribution of group II phospholipase A2 protein and mRNA in rat tissues. J Histochem Cytochem (2000) 0.76
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2012) 5.37
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31
Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med (2004) 2.10
Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol (2008) 1.93
Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids. Respir Med (2009) 1.26
Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates. Exp Gerontol (2009) 1.26
Alveolar inflammation in cystic fibrosis. J Cyst Fibros (2010) 1.11
Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol (2014) 1.06
Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest (2003) 1.02
Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg (2010) 1.01
Therapies for interstitial lung disease: past, present and future. Ther Adv Respir Dis (2008) 1.00
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis. Am J Respir Cell Mol Biol (2014) 0.96
Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant (2003) 0.93
Recurrent Clostridium difficile colitis in cystic fibrosis: an emerging problem. J Cyst Fibros (2012) 0.91
A continuous fluorescence assay for the determination of calcium-dependent secretory phospholipase A2 activity in serum. Clin Chim Acta (2007) 0.90
Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation. Interact Cardiovasc Thorac Surg (2011) 0.90
Parenteral nutrition suppresses the bactericidal response of the small intestine. Surgery (2012) 0.88
Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging (2007) 0.87
Redo lung transplantation for acute and chronic lung allograft failure: long-term follow-up in a single center. Eur J Cardiothorac Surg (2008) 0.87
IL-25 improves luminal innate immunity and barrier function during parenteral nutrition. Ann Surg (2014) 0.86
Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes. J Appl Physiol (1985) (2002) 0.85
The impact of the lung allocation scoring system at the single national Veterans Affairs Hospital lung transplantation program. Eur J Cardiothorac Surg (2009) 0.85
Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2013) 0.85
Lactate in cystic fibrosis sputum. J Cyst Fibros (2010) 0.84
Drug treatment of pneumococcal pneumonia in the elderly. Drugs Aging (2004) 0.84
Role of sensory input from the lungs in control of muscle sympathetic nerve activity during and after apnea in humans. J Appl Physiol (1985) (2004) 0.84
Ratio of "A-type" to "B-type" proanthocyanidin interflavan bonds affects extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells. J Agric Food Chem (2013) 0.84
The enteric nervous system neuropeptide, bombesin, reverses innate immune impairments during parenteral nutrition. Ann Surg (2014) 0.83
Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition. JPEN J Parenter Enteral Nutr (2013) 0.83
IPF clinical trial design and endpoints. Curr Opin Pulm Med (2014) 0.83
Parenteral nutrition increases susceptibility of ileum to invasion by E coli. J Surg Res (2013) 0.82
Comparison of isolated cranberry (Vaccinium macrocarpon Ait.) proanthocyanidins to catechin and procyanidins A2 and B2 for use as standards in the 4-(dimethylamino)cinnamaldehyde assay. J Agric Food Chem (2012) 0.82
IL-25 improves IgA levels during parenteral nutrition through the JAK-STAT pathway. Ann Surg (2013) 0.82
Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system. Eur J Cardiothorac Surg (2011) 0.82
Measurement of regional choroidal blood flow in rabbits and monkeys using fluorescent microspheres. Arch Ophthalmol (2006) 0.81
Parenteral nutrition impairs lymphotoxin β receptor signaling via NF-κB. Ann Surg (2011) 0.81
Barriers to optimal palliative care of lung transplant candidates. Chest (2013) 0.81
Displacement and strain estimation for evaluation of arterial wall stiffness using a familial hypercholesterolemia swine model of atherosclerosis. Med Phys (2012) 0.81
Colonic enteric nervous system analysis during parenteral nutrition. J Surg Res (2013) 0.80
Cranberry proanthocyanidins improve the gut mucous layer morphology and function in mice receiving elemental enteral nutrition. JPEN J Parenter Enteral Nutr (2012) 0.80
Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions. Chest (2015) 0.80
Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med (2008) 0.78
Optimizing post-transplant outcomes in lung transplantation. Expert Rev Respir Med (2008) 0.78
Non-acidic supraesophageal reflux associated with diffuse alveolar damage and allograft dysfunction after lung transplantation: a case report. J Heart Lung Transplant (2008) 0.78
Antithrombotic properties of the thromboxane A2/prostaglandin H2 receptor antagonist S18886 on prevention of platelet-dependent cyclic flow reductions in dogs. J Cardiovasc Pharmacol (2005) 0.78
Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: green is not good. J Lab Clin Med (2004) 0.77
Safety of and cellular response to segmental bronchoprovocation in allergic asthma. PLoS One (2013) 0.77
Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration. Ann Surg (2015) 0.76
Lung transplantation for advanced bronchiectasis. Semin Respir Crit Care Med (2010) 0.75
Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis. BMC Pulm Med (2012) 0.75
Reply: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2013) 0.75
Revisiting an old therapy for tuberculosis. Respir Care (2009) 0.75
Measurements of wall shear stress and aortic pulse wave velocity in swine with familial hypercholesterolemia. J Magn Reson Imaging (2014) 0.75
Reply: performing bronchoalveolar lavage as per the ATS guidelines 2012. Am J Respir Crit Care Med (2013) 0.75
Interferon gamma-1b therapy for idiopathic pulmonary fibrosis: is the cart before the horse? Mayo Clin Proc (2003) 0.75
Supercritical fluid extraction (SFE) of cranberries does not extract oligomeric proanthocyanidins (PAC) but does alter the chromatography and bioactivity of PAC fractions extracted from SFE residues. J Agric Food Chem (2014) 0.75
Lung transplantation for high-risk patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2016) 0.75
Clinical year in review IV: HIV, mycobacterial disease, pulmonary hypertension, and interstitial lung disease. Proc Am Thorac Soc (2012) 0.75
An international ISHLT/ATS/ERS clinical practice guideline: summary for clinicians. Bronchiolitis obliterans syndrome complicating lung transplantation. Ann Am Thorac Soc (2015) 0.75